| Name: | Darifenacin Impurity A |
| Catalogue No. | VL1530001 |
| CAS No. | 1048979-16-3 |
| Molecular Formula | C28H29NO3 |
| Molecular Weight | 427.21 |
| Status | In-stock |
| IUPAC Name | (R)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetic acid |
| Synonyms | Darifenacin Carboxylic Acid |
| Description | Darifenacin Impurity A (CAS No.: 1048979-16-3) or Darifenacin Carboxylic Acid is an abundant metabolite of Darifenacin. Darifenacin is a selective muscarinic M3-receptor inhibitor that has been evaluated for use in clinical trials in patients with overactive bladder syndrome (OAB) using a controlled-release formulation. |
| References | Nilvebrant, L., et al. “Tolterodine-a New Bladder Selective Muscarinic Receptor Antagonist: Preclinical Pharmacological and Clinical Data.” Life Sciences, vol. 60, no. 13-14, Feb. 1997, pp. 1129–36,https://doi.org/10.1016/s0024-3205(97)00057-x.Croom, Katherine F., and Gillian M. Keating. “Darifenacin.” Drugs & Aging, vol. 21, no. 13, 2004, pp. 885–92,https://doi.org/10.2165/00002512-200421130-00005. |
